CircaGene
London
About CircaGene
CircaGene is building the future of genetic testing. Direct to Consumer platform where users can order personal genetic tests through total privacy (Patented new encryption Number 1907358.4) with actionable results to reduce health Risk and enhance lifestyle and health. CircaGene provides End-to-end Encryption guaranteeing that only the user can have access to his results, protecting Genetic Privacy. Sequencing Services that put in relation Consumers with the best Genetic Research algorithms, easy to navigate reports, and connection to third parties with consistent healthcare. CircaGene can be described as the “Uber” of Genetic testing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $230.0K
- Funding stage: Seed
- Last round: Pre-Seed (Apr 2020)
- Website: circagene.com
- Phone: [email protected]
Industries & Categories
Bioinformatics, Genetics, Health Care, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/circagene-106260 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.